Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 8201 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 8202 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 64 |
| 8203 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 48 |
| 8204 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 49 |
| 8205 | Apheresis | Allogeneic | Multiple Myeloma, Second Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 64 |
| 8206 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 57 |
| 8207 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 60 |
| 8208 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 29 |
| 8209 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 73 |
| 8210 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 62 |
| 8211 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 22 |
| 8212 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 8213 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2015 | Standard Therapy | Germany | 54 |
| 8214 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 8215 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 41 |
| 8216 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 8217 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 8218 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 44 |
| 8219 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2014 | Experimental Therapy | Poland | 6 |
| 8220 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2014 | Experimental Therapy | Poland | 60 |
| 8221 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2014 | Experimental Therapy | Poland | 24 |
| 8222 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2014 | Experimental Therapy | Poland | 12 |
| 8223 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2014 | Experimental Therapy | Poland | 8 |
| 8224 | Cord Tissue | Allogeneic – Unrelated | Birth Asphyxia; Retinopathy | Neurology | 2014 | Experimental Therapy | Poland | 11 |
| 8225 | Cord Tissue | Allogeneic – Unrelated | Central Motor Coordination Impairment After Hypoxic Ischemic Lesion At Birth | Neurology | 2014 | Experimental Therapy | Poland | 2 |
| 8226 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Poland | 4 |
| 8227 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Poland | 15 |
| 8228 | Cord Tissue | Allogeneic – Unrelated | Muscular Dystrophy | Neurology | 2014 | Experimental Therapy | Poland | 6 |
| 8229 | Cord Tissue | Allogeneic – Unrelated | Neuropathy | Neurology | 2014 | Experimental Therapy | Poland | 23 |
| 8230 | Cord Blood | Allogeneic – Unrelated | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Spain | 15 |
| 8231 | Cord Blood | Allogeneic – Related | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Turkey | 8 |
| 8232 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Germany | 45 |
| 8233 | Cord Blood | Autologous | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Portugal | 6 |
| 8234 | Cord Blood | Allogeneic – Related | Beta Thalassemia | Hematology | 2014 | Standard Therapy | Germany | 6 |
| 8235 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Portugal | 4 |
| 8236 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | UK | 1 |
| 8237 | Cord Blood | Autologous | Hsv Encephalitis And Nmda Receptor Antibody Encephalitis | Neurology | 2014 | Experimental Therapy | UK | 2 |
| 8238 | Cord Blood | Autologous | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2014 | Experimental Therapy | UK | 3 |
| 8239 | Cord Blood | Allogeneic – Related | Leukemia | Hematology | 2014 | Standard Therapy | UK | 4 |
| 8240 | Cord Blood | Autologous | Severe Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 11 |
| 8241 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 35 |
| 8242 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 73 |
| 8243 | Bone Marrow | Allogeneic | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2014 | Standard Therapy | Germany | 44 |
| 8244 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 8245 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 8246 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 8247 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 8248 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 8249 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 8250 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 29 |
| 8251 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 76 |
| 8252 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 48 |
| 8253 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 53 |
| 8254 | Apheresis | Allogeneic | Acute Myeloid Leukemia – Relapse | Hematology | 2014 | Standard Therapy | Germany | 45 |
| 8255 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 27 |
| 8256 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 44 |
| 8257 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 46 |
| 8258 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma – Relapse | Hematology | 2014 | Standard Therapy | Germany | 67 |
| 8259 | Apheresis | Autologous | Bing–Neel Syndrome; Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 64 |
| 8260 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2014 | Standard Therapy | Germany | 42 |
| 8261 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2014 | Standard Therapy | Germany | 57 |
| 8262 | Apheresis | Allogeneic | Composite Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 8263 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 53 |
| 8264 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 50 |
| 8265 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 63 |
| 8266 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2014 | Standard Therapy | Germany | 24 |
| 8267 | Apheresis | Autologous | Lymphoma-Relapse | Hematology | 2014 | Standard Therapy | Germany | 56 |
| 8268 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 8269 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 62 |
| 8270 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 58 |
| 8271 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 62 |
| 8272 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 8273 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 8274 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 68 |
| 8275 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 8276 | Apheresis | Autologous | Marginal Zone Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 8277 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2014 | Standard Therapy | Germany | 31 |
| 8278 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 44 |
| 8279 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 37 |
| 8280 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 19 |
| 8281 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 70 |
| 8282 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 71 |
| 8283 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 8284 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 71 |
| 8285 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 66 |
| 8286 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 8287 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 53 |
| 8288 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 8289 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 8290 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 30 |
| 8291 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 64 |
| 8292 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 70 |
| 8293 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 77 |
| 8294 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 8295 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 8296 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 8297 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 63 |
| 8298 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 63 |
| 8299 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 68 |
| 8300 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 49 |